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1. Introduction 
Encephalitis, inflammation of the brain, is a rare condition in humans characterised by a 
triad of clinical features that include fever, headache and an altered level of consciousness 
that can persist for over 24 hours. There are many causes for the condition ranging from 
infection with an array of pathogens to autoimmune reactions. A major cause, and the one 
which this review will focus on, are viral infections (Whitley and Gnann, 2002). A diverse 
range of viruses are capable of invading the Central Nervous System (CNS) and infecting a 
variety of cell types within it (Tyler, 2009a; Tyler, 2009b). Examples from a range of viral 
species will be used to illustrate initial infection of the CNS, early innate immune responses, 
viral evasion of these early responses and the development of the adaptive immune 
response. The majority of viral CNS infections are transient but some can lead to long- term 
disability or death. 
Structurally, the CNS consists of the brain and spinal cord that are both encased within 
bone. Three membranes surround the brain, which are collectively called the meninges. 
These are the thick dura mater, the web-like arachnoid mater and the delicate pia mater. 
This structure can itself become inflamed giving rise to meningitis. Within this, the brain is 
divided at a gross level into the forebrain containing the frontal, parietal, occipital and 
temporal lobes, and the hindbrain containing specialist structures including the 
hippocampus, pituitary and cerebellum. Below this is the brainstem that connects the brain 
to the spinal cord that extends through the body of all vertebrates. Neuronal processes leave 
the spinal cord to innervate the organs and structures of the body through sensory and 
motor neurons, forming the peripheral nervous system. The cellular content of the CNS is 
varied. The key cell-type is the neuron although this only constitutes around 5% of the 
cellular total and can vary between regions of the brain. Neurons typically have a large cell 
body containing the nucleus, from which extensions, termed axons extend. At the termini of 
axons, small processes or dendrites make contact with other neurons creating an extensive 
network of connections enabling the brain to act as an information-processing centre for the 
organism. In addition to neurons are cells collectively termed glia. Glial cells support 
neurons through a range of functional phenotypes. Astrocytes assist in sustaining neuronal 
metabolism and neurotransmission. Oligodendrocytes have elongated processes that 
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surround axons and produce myelin, which effectively insulates axonal processes and 
enables efficient electrical transmission along axons. Finally, microglia provide an immune 
function within the CNS, acting as the resident macrophage population removing dead 
cells, and are particularly important in the development of the foetal brain. 
Infection of the leptomeninges (aracnoid mater and pia mater) generally does not result in 
serious disease. However, infection of glial cells and neurons can result in acute disease 
through direct cellular destruction and/or the initiation of immune pathology. The loss of 
non-renewable, specialized cells responsible for cognition, mobility and almost all organ 
function can have profound impact on the host. The immediate consequence of infection is 
inflammation, manifest as viral encephalitis, the outcome of which can vary from a transient 
episode to long term neurological deficit or in the death of the host.  The pathology of 
disease is characterised by a cellular thickening of blood vessels or perivascular cuffing and 
a proliferation of astrocytes, or gliosis. Changes are also observed in the cerebro spinal fluid 
(CSF) including the presence of predominantly mononuclear cells (pleocytosis), increased 
levels of protein and antibodies. Infecting viruses can be detected in the CSF using specific 
molecular tests such as the polymerase chain reaction (PCR). 
When considering any host-pathogen relationships within the CNS, the issue of immune-
privilege must be acknowledged.  The CNS is considered an immuno-privileged site, a term 
first coined by Peter Medawar resulting from the observation that allografts placed in 
certain locations, such as the eye or brain were not rejected by the immune system with the 
rapidity observed in other organs (Brent, 1990). The cause of this privilege has been 
attributed almost exclusively to the barrier separating the periphery from the CNS, which is 
collectively termed the blood-brain barrier (BBB). At a basic level this is formed by the 
endothelium found on the luminal side of blood vasculature within the brain (Bailey et al., 
2006). Tight junctions between endothelial cells prevent entry of cells, large molecules and 
proteins. Furthermore, under normal conditions these endothelial cells express no or very 
low levels of adhesion molecules preventing attachment of immune cells and blocking a 
potential route of entry for cells involved in immune surveillance. Surrounding the 
endothelial cells, on the CNS side, is a thick basement membrane that is itself surrounded by 
processes from astrocytes termed astrocytic end feet. The BBB is present over 99% of the 
brain vasculature. The exceptions are those structures that are involved in hormone 
secretion such as the pituitary and hypothalamus where free movement of proteins is 
required between neural tissue and the blood. In addition there are no lymphatic vessels 
within the parenchyma of the brain that would provide a conduit for antigen presenting 
dendritic cells to move directly to lymphoid tissue. However, it would be wrong to assume 
that the absence of comparable cells and structures found in the periphery represents an 
absence of these functions. Numerous studies are now identifying the multiple mechanisms 
of immune surveillance that support the CNS, initiating both protective and damaging 
immune responses (Hickey, 2001). Likewise there are now defined routes by which immune 
cells can enter the CNS, particularly in response to infection (Ransohoff et al., 2003). The 
appropriate and timely orchestration of these events is critical in responding to viral 
infection particularly in the early chemokine and cytokine signals that trigger the innate 
immune response. Much research has been conducted in recent years on these early 
responses with some mediators being observed repeatedly, such as the chemokine CXCL10, 
in response to viral infection. This in turn has dramatic consequences for the vasculature 
without apparently changing the efficacy of the BBB. Adjunct to this is the activation of the 
adaptive response to viral infection within the CNS. In this area less is known of the 
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mechanism that leads to antigen presentation from this site. Key questions that are raised by 
this include the mechanism of antigen transfer from the CNS to sites of antigen presentation, 
the timescale of these events and the fate of effecter cells that eventually migrate to the site 
of infection. The coordination of immune activation and appropriate response are poorly 
understood and can result in a continuum of outcomes that vary from complete resolution 
of the infection, latent infection by the virus, severe encephalitis and cell-mediated 
destruction of host cells. 
This review will follow the theoretical events that occur following neuroinvasion in humans 
by viruses that result in encephalitis. This will include: 
 A brief overview of viruses that cause encephalitis. This focuses mainly on those that 
infect humans although includes a number that have been used extensively in murine 
experimental models. 
 An examination of the early innate immune response generated within the CNS to viral 
infection. This will also consider the cell-types that these signals target that prepare the 
tissue for the immune response. Also of importance will be the mechanisms that viruses 
use to subvert the immune response at this early stage. 
 Consideration of antigen presentation from CNS, which has been traditionally been 
considered an immuno-privileged site. In addition, the process of antibody-secreting 
cell development within lymphoid tissue and then migration to the CNS will be 
reviewed. 
 The review will conclude with the final steps of leukocyte recruitment across the BBB 
and discuss the variable outcomes to infection with different viruses. This appears to be 
determined as much by the response of the host as the virulence of the virus. 
2. Viruses that cause encephalitis 
Many viruses have been identified as the causative agent of encephalitis. Table 1 gives a 
summary of many of the virus species that are associated with human and/or animal 
encephalitis. It is noteworthy that most have ribonucleic acid (RNA) genomes. Many are 
found worldwide although some, particularly those that are associated with an arthropod 
vector, have a more limited distribution. Most are established causative agents of disease. 
2.1 Herpesviruses that cause encephalitis 
Herpes viruses are one of the few groups that preferentially infect neurons or show 
neurotropism. Herpes simplex virus type 1 infects trigeminal ganglia and establishes a 
latent infection. Periodically, the virus reactivates and returns to the site which the ganglia 
innervates, causing a vesicular rash. Virus is released into the exudate and can be 
transmitted onwards through contact. This cycle occurs repeatedly through the life of the 
infected individual but occasionally this can develop into encephalitis in both 
immunocompetent and particularly immunocompromised individuals (Kleinschmidt-
DeMaster and Gilden, 2001). A recent investigation into the causes of encephalitis in 
England found that 42% could be attributed to infectious disease with 19% being caused by 
herpes simplex virus and 5% being caused by varicella zoster virus (Granerod et al., 2010). A 
further 30% were caused by immune-mediated encephalitis. However, the largest group 
(42%) were of unknown origin, some of which could have had a viral aetiology but not 
diagnosed. Similar findings were made from a retrospective study of encephalitis in 
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Australia with Herpes simplex viruses being the most common virus associated with human 
encephalitis (Huppatz et al., 2010), although in this study, flaviviruses such as Murray 
Valley encephalitis virus and Kunjin virus were also reported. 
2.2 Arthropod-borne viruses that cause encephalitis 
Prominent amongst the viruses that cause encephalitis are the flaviviruses (Gould and 
Solomon, 2008). These are transmitted by an arthropod vector (mosquitoes and ticks) and 
thus disease characteristically occurs in human populations in synchrony with seasonal 
peaks in vector abundance. In the Northern Hemisphere this is typically late summer for 
mosquito-borne infections. Infection with arthropod-borne viruses usually results in 
replication in lymphoid tissue close to the bite site that results in a transient viraemia and 
febrile illness. The viraemia following infection with some viruses, either through its 
transient nature or low titres, does not result in onward transmission to the vector such as 
the case of West Nile virus and humans are a dead end host. However, in other cases, 
human infection is critical to maintaining the infection such as in outbreaks of chikungunya 
virus (see below). Encephalitis usually occurs subsequent to the resolution of viraemia. The 
flavivirus genus includes viruses such as mosquito-borne West Nile virus, which following 
its introduction into the United States in 1999 resulted in a sharp increase in human cases of 
encephalitis as it rapidly spread west (Granwehr et al., 2004).  In experimental studies, West 
Nile virus is highly neurovirulent in mice, spreading rapidly though the brain. Figure 1 
illustrates the rapid spread of West Nile virus following intranasal infection. The 
morphology of infected cells indicates that they are predominantly neuronal. Another 
prominent member of this genus is Japanese encephalitis virus, present throughout Asia. 
Mortality rates can reach 30% with a further 50% having severe neurological sequelae 
(Tyler, 2009a). In addition to mosquito-borne viruses, the flaviviruses also include tick-borne 
viruses of which the most prominent is tick-borne encephalitis virus (TBEV) found in an 
uninterrupted belt from Western Europe to the far east of Asia (Mansfield et al., 2009). The 
virus is transmitted by Ixodes species of ticks and is currently increasing in many countries, 
likely through changes in human behaviour such as leisure pursuits that bring humans into 
areas inhabited by ticks.  TBEV causes asymptomatic infection in wildlife but can result in 
severe encephalitis in humans. The exception to this is a variant of TBEV named louping ill 
virus found almost exclusively in the United Kingdom that has been rarely associated with 
human illness but causes fatal encephalitic disease in sheep and grouse (Sheahan et al., 
2002). 
Another group of mosquito-borne viruses capable of causing encephalitis is the genus 
Alphavirus (Zacks and Paessler, 2009). Prominent among these are the equine 
encephalitides of North, Central and South America  Although less rarely associated with 
human encephalitis, infection with Eastern equine encephalitis virus can be devastating 
with mortality rates ranging between 50 and 75%. As the names of these virus indicates, 
they also cause severe encephalitis in horses with mortality rates reaching up to 90%. This 
group also includes emerging viruses such as chikungunya virus, that has caused explosive 
outbreaks of febrile disease in countries around the Indian Ocean that have sporadically 
been transported back to Europe by infected individuals. In one year this resulted in 
autochthonous transmission of chikungunya virus in Italy potentially vectored by the 
invasive mosquito species Aedes albopictus (Seyler et al., 2008).  
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Fig. 1. Spread of West Nile virus through the murine brain following intranasal infection. 
Individual mice were inoculated with West Nile virus and sampled at the time points 
indicated. Serial 4 m sections were cut and stained with a monoclonal antibody specific for 
the West Nile virus envelope protein. Brown staining indicates detection of West Nile virus 
within regions of the brain indicated. 
2.3 Lyssaviruses that cause encephalitis 
One group of viruses of special note are the lyssaviruses of which every member is believed 
to be neurotropic and capable of causing encephalitis. This group is dominated by the rabies 
virus, a virus that infects all mammals and is transmitted by animal bites that with rare 
exceptions cause fatal encephalitis in all those where infection reaches the brain (Rupprecht 
et al., 2002). Estimates are vague on the actual number of annual deaths due to rabies, 
particularly in regions of the world with poorly developed public health infrastructures but 
figures upwards of 50,000 are regularly quoted. Transmission of rabies virus occurs when 
virus is deposited within skin or muscle following a bite and if not treated either by wound 
cleansing or vaccination, infects neurons close to the wound. The virus then ascends rapidly 
to the CNS by retrograde axonal transport leading to replication within the spinal cord and 
brain (Schnell et al., 2010). Vaccination post-bite is highly effective and has virtually 
eliminated rabies as a human disease in the Americas and Europe. The main human burden 
of this disease falls in Asia and Africa where the cost of treatment or ignorance prevents its 
use. The lyssavirus genus also contains viruses that are associated with certain bat species 
and that on occasion have resulted in human fatalities following contact with an infected 
bat. These viruses appear to have a limited geographical distribution (Fooks et al., 2003; 
Johnson et al., 2010). 
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2.4 Emerging viruses that cause encephalitis 
Others species are considered emerging viruses (Tyler, 2009a). Human immunodeficiency 
virus is a prime example of a virus emerging as a recognised disease in the 1970s. The virus 
emerged in the human population following a jump from primates into man in Africa at a 
much earlier point in the century (Zhu et al., 1998; Tebit and Arts, 2011). It has spread 
rapidly and continues to be a global public health problem. In addition to progressive 
immunodeficiency, up to one third of individuals infected with HIV-1 develop encephalitis 
(Lipton and Gendelman, 1995).  
Another virus that has emerged, particularly in Italy as one of the major causes of encephalitis, 
is Toscana virus and the closely related virus Naples sandfly fever (Tyler, 2009a). The virus is 
transmitted by sandflies (Phlebotomus perniciosus) during the summer months causing mild 
febrile illness that can develop into severe encephalitis (Dionisio et al., 2001). 
Further examples include the recently described Hendra and Nipah viruses (Tyler, 2009b). 
Hendra virus was first isolated in 1994 as a result of disease affected horses in Brisbane, 
Australia, that in turn lead to disease amongst veterinarians who treated the animals 
(Tulsiani et al., 2011). Subsequent investigation demonstrated that the virus had made the 
jump from its natural host, pteropid fruit bats, into an amplifying host, the horse, from 
which it then made the jump to humans. A similar sequence of events occurred with the 
emergence Nipah virus that caused an outbreak of acute encephalitis among Malaysian pig 
handlers in 1998, with farmed pigs acting as the amplifying host. Immunohistochemical 
analysis of autopsy specimens observed extensive parenchymal necrosis with widespread 
Nipah virus antigen staining associated with the smooth muscle of blood vessels (Wong et 
al., 2002). Again, fruit bats were identified as the original host of the virus and the Malaysian 
outbreak was controlled by mass slaughter of pigs. Repeated sporadic outbreaks of Nipah 
virus infections continue to occur in Asia. 
2.5 Rare viral encephalopathies 
Although more commonly associated with haemorrhagic fever, Lassa fever virus can cause 
encephalopathy during the course of infection (Cummins et al., 1992). A related virus, 
lymphocytic choriomeningitis virus, is used as a model for encephalitis in mice. Measles 
virus is a common childhood infection which usually resolves rapidly with no neural 
involvement. However a small number of cases develop subacute sclerosing panencephalitis 
(SSPE), a fatal condition in which the virus persists in the brain, spreading through the CNS 
causing progressive demyelination and destruction of neurons (Allen et al., 1996). 
3. Innate response to viral infection of the Central Nervous System 
Entry of virus into the CNS can be haematogenous, resulting from changes in the 
vasculature that enable virus to cross the blood-brain-barrier either directly or within 
infected cells crossing the endothelium. Alternatively entry can be neuronal of which rabies 
virus and herpes viruses are the best characterised. By the haematogenous route there is 
likely to have been prior virus replication in the periphery often resulting in a detectable 
viraemia and an opportunity for systemic immune activation and an adaptive response 
demonstrable by the presence of anti-virus antibodies in serum. There is usually a febrile 
phase that often resolves and the appearance of virus-neutralising antibodies in the blood 
that rapidly controls viraemia. Entry by the neuronal route may occur with minimal virus 
replication in the periphery and therefore the first contact between the immune response   
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Virus Family Genome Virus Species 
Geographical 
Distribution 
    
Adenoviridae 
Double-stranded 
DNA 
Adenovirus Worldwide 
Arenaviridae 
Single-stranded RNA 
(negative sense, 
segmented) 
Lassa fever virus West Africa 
  
Lymphocytic 
choriomeningitis virus 
Worldwide 
Bunyaviridae 
Single-stranded RNA 
(negative sense, 
segmented) 
California encephalitis 
virus 
North America 
   Worldwide 
  Rift Valley fever virus Africa 
  Toscana virus Europe 
  La Crosse virus North America 
Flaviviridae 
Single-stranded RNA 
(negative sense, non-
segmented) 
Japanese encephalitis virus Asia 
  Kyasanur Forest virus India 
  Louping ill virus United Kingdom 
  
Murray Valley 
encephalitis virus 
Australia 
  St. Louis encephalitis 
North and South 
America 
  
Tick-borne encephalitis 
virus 
Europe and Asia 
  West Nile virus Worldwide 
Herpesviridae 
Double-stranded 
DNA 
Human herpes virus 1 
(Herpes simplex virus) 
Worldwide 
  
Human herpes virus 3 
(Varicella zoster virus) 
Worldwide 
  Human herpes virus 6 Worldwide 
Orthomyxoviridae 
Single stranded RNA 
(negative sense, 
segmented) 
Influenza A virus Worldwide 
Paramyxoviridae 
Single stranded 
RNA, (negative 
sense, non-
segmented) 
Mumps virus Worldwide 
  Measles virus Worldwide 
  Nipah virus Asia 
  Hendra virus Australia 
Picornaviridae 
Single stranded RNA 
(positive sense, non-
segmented) 
Poliovirus Africa 
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Virus Family Genome Virus Species 
Geographical 
Distribution 
  Coxsackie virus Worldwide 
  Echovirus Worldwide 
Retroviridae 
Single stranded RNA 
(positive sense, non-
segmented). Capable 
of integration into 
the host genome 
through a DNA 
intermediate 
genome. 
Human 
Immunodeficiency virus 
Worldwide 
Rhabdoviridae 
Single-stranded RNA 
(negative sense, non-
segmented) 
Rabies virus Worldwide 
  Duvenhage virus Africa 
  
European bat lyssavirus 
type 1 
Europe 
  
European bat lyssavirus 
type 2 
Europe 
  Australian bat lyssavirus Australia 
Togaviridae 
Single-standed RNA 
(negative sense, non-
segmented). 
Eastern equine 
encephalitis virus 
North and South 
America 
  
Western equine 
encephalitis virus 
North America 
  
Venezuelan equine 
encephalitis virus 
North and South 
America 
  Chikungunya virus Africa and Asia 
Table 1. Viruses that cause encephalitis 
and infecting virus occurs within the CNS and can provide a direct challenge to the survival 
of the host. In this case, the earliest response to the appearance of virus within the CNS is 
the innate-immune response. 
Innate immune responses are activated by recognition of pathogen-associated molecular 
patterns or PAMPs. For viruses, this includes surface glycoproteins and structures 
associated with single- or double-stranded RNA. Recognition is mediated by a number of 
protein families, the most prominent being the toll-like receptors (TLRs), NOD-like 
receptors and RIG-I helicases (Creagh and O’Neill, 2006; Rehwinkel and Reis e Sousa, 2010). 
These receptors are expressed in many compartments of the cell and trigger the production 
of type I interferons, a key element in controlling virus replication and spread (Randall and 
Goodbourn, 2008). Type 2 interferons are produced exclusively by lymphoid cells, which are 
absent early in infection but contribute to later control of pathogens. Interferons in turn 
activate the up-regulation of a large number of proteins that act to control infection at the 
cellular level and attract immune effector cells. Three mechanisms of direct inhibition of 
virus replication have been identified. Activation of protein kinase R (PKR) in response to 
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double stranded RNA (e.g. virus replication intermediates) which inhibits eukaryotic 
translational factor 2 that in turn restricts synthesis of viral proteins. Activation of 2’5’ 
oligoadenylate synthetase (OAS), which activates RNase L and in turn degrades viral RNA. 
Finally, the Mx family of proteins are activated that target nucleocapsids (viral structures 
that contain the genome bound to viral proteins including the nucleoprotein, a protein 
encoded by many viruses). Whilst the CNS has unique immunological status there is 
increasing evidence that there is a vigorous innate immune response to viral infection of 
cells within it (Savarin and Bergman, 2008). For example, TLRs are selectively up-regulated 
in the brain in response to infection with different viruses (McKimmie et al., 2005). Neurons 
can produce a range of innate immune-associated proteins including type 1 interferons in 
response to infection with rabies virus (Prehaud et al., 2005), Theilers virus and La Crosse 
virus (Delhaye et al., 2006). Microglial cells are capable of producing a wide range of 
inflammatory mediators in response to activation (Rock et al., 2004) or direct infection 
(Nakamichi et al., 2005). 
Unsurprisingly, viruses have evolved a range of mechanisms to subvert the innate immune 
response, particularly through inhibition of the interferon system (Randall and Goodbourn, 
2008). These often involve direct interaction of virally expressed proteins with signaling 
intermediates that would normally trigger the expression of interferon or interferon-induced 
proteins. Many such viral proteins have multiple roles, both in viral replication and 
subversion of the immune response. The influenza virus NS1 protein inhibits export of host 
mRNA from the nucleus during infection (Satterley et al., 2007) whereas the La Crosse virus 
nonstructural protein NSs targets inhibition of type 1 interferon production (Blaqori et al., 
2007). The rabies virus phosphoprotein blocks interferon signaling through interaction with 
interferon regulatory factor 3 (Brzozka et al., 2005) and STAT proteins (Chelibi-Alix et al., 
2006; Brzozka et al., 2006; Vidy et al., 2007).  
Whilst innate immune inhibition occurs within the cell, neuroinvasion by viruses rapidly 
induces immune responses across the CNS (See Figure 2). A key family of proteins 
produced in response to infection are the chemokines whose primary role is to attract 
immune effecter cells to sites of infection.  The chemokine family consists of a growing 
number of small proteins (<100 amino acids) that are produced at sites of pathology. They 
contain four conserved cysteine residues that form structurally critical disulphide bonds. 
The position of the first two cysteines, either adjacent (CC) or separated by a single amino 
acid (CXC) dictates the current naming of chemokines (Baggiolini, 1998).  These in turn bind 
to specific receptors expressed on target cells. A summary of a number of well-characterized 
chemokines is shown in Table 2. 
  
Current name Former name Receptors Receptor expressed on 
CCL2 MCP1 CCR2 Monocytes, activated T cells 
CCL3 MIP-1 CCR1,4,5 Activated T cells 
CCL4 MIP-1 CCR5 Monocytes, activated T cells 
CCL5 RANTES CCR1,3,4,5 Monocytes, activated T cells 
CXCL10 IP-10 CXCR3 Activated T cells 
Table 2. Summary of a small number of human chemokines and their receptors 
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Studies of in vivo models generally show transcriptional up-regulation of a wide range of 
chemokines in the CNS following viral infection. Numerous studies using murine models of 
infection have consistently shown up-regulation of chemokines including those on rabies 
virus (Wang et al., 2005) and this is associated with infiltration of mononuclear cells, 
particularly T cells (Johnson et al., 2008). Likewise, West Nile virus infection up-regulates a 
wide range of pro-inflammatory genes within the murine brain (Venter et al., 2005), 
prominent among these is CXCL10. Figure 2 shows the transcriptional up-regulation of a 
small panel of chemokines from time-points that correspond with those in Figure 1. Most 
show a detectable up-regulation by day 4 with CXCL10 showing the greatest increase both 
temporally and in magnitude. Functionally, expression of CXCL10 leads to recruitment of 
CD8+ T-cells and control of infections such as West Nile virus and lymphocytic 
choriomeningitis virus (Klein et al., 2005; Christensen et al., 2006). Conversely, the majority 
of T cells entering the CNS express the CXCL10 receptor CXCR3 (Stiles et al., 2006) and 
expression of this receptor is critical for targeting CD8+ T cells to specific regions of the CNS 
(Zhang et al., 2008). 
 
 
 
 
Fig. 2. Expression of interferon  and selected chemokine transcripts following intranasal 
infection with West Nile virus. Groups of three mice were infected with West Nile virus by 
the intranasal route and sampled at the time points indicated. Total RNA was extracted 
from whole brain and the level of transcript was measured by quantitiative real-time reverse 
transcription polymerase chain reaction as previously described (Johnson et al., 2008).  
Many cytokines are toxic to neurons and oligodendrocytes including IL1, TNF-and 
interferon-. Uncontrolled cytokine expression would inevitably lead to tissue damage, a 
situation that occurs in auto-immune mediated encephalopathies such as multiple sclerosis 
and Alzheimer’s disease. It is therefore not suprising to find mechanisms for controlling 
inflammation within the CNS. Innate immune responses are suppressed by TGF-, 
produced by resting and active astrocytes (Constam et al., 1992). During inflammation, the 
family of suppressors of cytokine signaling (SOCS) proteins are induced by cytokine 
expression and block signal transduction activated by these same cytokines providing 
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feedback inhibition of inflammation (Yoshimura et al., 2007). There is also evidence that 
these proteins are selectively expressed in the brain to control inflammation in response to 
viral infection (Mansfield et al., 2010). A delicate balance is required to ensure that 
inflammation, a natural response to infection and vital to initiate the process of infection 
resolution does not result in excessive cellular destruction. It is also clear that innate 
immune responses are not alone capable of controlling and eliminating the cause of 
infection and that an adaptive response is required. 
4. Antigen presentation, lymphatic drainage and the development of the 
adaptive immune response 
The adaptive immune response to CNS infection is presented with a unique challenge 
compared to other sites within the body. There appears to be limited antigen presentation 
capacity within the CNS and no lymphatic drainage vessels. There is no lymphoid tissue 
within the CNS in which antigen responses can develop and activated immune cells that 
develop externally to the CNS need to cross the BBB in order to reach locations where they 
are required. Direct viral infection can lead to disruption of the BBB such as the infection of 
endothelial cells by Semliki Forest virus in a murine model of disease (Soilu-Hanninen et al., 
1994). However, during the early stages of most infections the BBB remains intact, indeed it 
is possible that failure to open the BBB may be a contributory factor in the failure to control 
rabies virus infection (Roy et al., 2007). The ability to detect, present and rapidly respond to 
the presence of virus are critical determinants in controlling infection. 
Throughout the body, the principal cell-type that detects non-host antigens are 
plasmacytoid dendritic cells that present antigen on the cell surface to other cell-types of the 
adaptive immune system. They are also the main type 1 interferon producing cells. 
However, cells with dendritic cell morphology and phenotype are absent from the CNS 
(Hart and Fabre, 1981). A possible alternative within the CNS is the microglia cell 
component, which in some areas of the CNS form over 15% of the cellular composition 
(Rock et al., 2004). In their resting form, microglia express very low levels of MHC class II 
molecules, but this along with a range of co-stimulatory molecules are up-regulated when 
microglia enter an activated state enabling antigen presentation (Constam et al., 1992; 
Fischer and Reichmann, 2001). In addition, there appears to be a discrete population of 
dendritic cells associated with the vascular endothelium within the brain that could provide 
antigen-presenting function (Gieber et al., 2005) and could act to draw immune effectors into 
the CNS. 
A key challenge to understanding the development of the adaptive immune response is to 
find appropriate means of introducing antigen or pathogen into the CNS without disruption 
of the BBB. It has long been recognised that direct injection of large volumes (upto 30l) 
causes a dramatic increase of intra-cranial pressure leading to the expulsion of most of the 
inoculum into peripheral locations (Cairns, 1950; Mims 1960). One means of overcoming this 
has been the inoculation of laboratory animals with stereotactically guided small volumes of 
virus (< 2 l). Stevenson and co-workers used this approach to study influenza virus 
infection in mice. Inoculation of virus into the CSF or intranasally resulted in a rapid 
induction of IgM (2-4 days) and IgG (3-5 days), and proliferative responses from cells 
prepared from cervical lymph nodes were observed 10 days after inoculation. However, 
direct inoculation of virus into the brain parenchyma failed to induce either antibody of 
cellular responses despite demonstration of virus replication within the brain (Stevenson et 
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al., 1997). This scenario reflects the antibody responses observed in rabies patients. Infection 
of peripheral nerves occurs in the skin or muscle, subsequent retrograde axonal transport 
enables the virus to ascend directly into the CNS accompanied by a rapid increase in 
replication. It is possible in most infections with rabies virus that no replication occurs 
within the periphery and thus rabies virus bypasses normal immune surveillance and 
response. Hence few patients have detectable levels of antibody on admission with disease 
(Noah et al., 1998; Hunter et al., 2010). These observations suggest that under some 
circumstances, the adaptive immune response to antigen or whole virus is delayed. 
A further obstacle to development of the immune response is the absence of a discrete 
lymphatic vasculature. This has gradually undergone revision with the recognition that this 
must occur. There is a net influx of fluid into the CNS that requires some form of drainage 
(Cserr and Knopf, 1992). Up to 50% of protein introduced into the brain of laboratory 
animals could be detected in the cervical lymphatics and that this can be extremely rapid 
with tracer being detected in deep cervical lymph nodes within six hours (Yamada et al., 
1991). It is now recognised that there are discrete drainage routes from the CNS and these 
include passage through the arachnoid villi into the blood supplying the dural sinus. There 
is also drainage to the lymph system along spaces adjacent to the cranial and spinal nerves, 
and through the Virchow-Robin perivascular spaces surrounding brain blood vessels 
(Knopf et al., 1995; Kida et al., 1995). Antibody secreting cells responding to CNS antigen 
can be detected in cervical lymph nodes and removal of these lymph nodes in experimental 
animals following introduction of antigen ablates the antibody response (Knopf et al., 1995). 
However, it is not clear that the response to virally infected cells and thus cellular associated 
virus will have the same dynamics and kinetics as soluble antigen. Recent studies have 
shown that activated CD4+ cells can traffic from the brain parenchyma to the nasal mucosa 
and cervical lymph nodes, using a similar route to that of soluble antigen (Goldmann et al., 
2006). This opens the possibility that classical antigen presentation is possible from within 
the CNS leading to development of virus specific immune cells within lymphoid tissue that 
are external in the presence of an intact BBB. Although this fails to explain the late 
emergence of antibodies to rabies virus in patients that present with disease (Noah et al., 
1998). 
5. Leukocyte recruitment and immune control of infection 
The mechanism that directs activated immune cells from lymphoid tissue to particular 
organs has not been elucidated. However, some form of targeting is likely to occur in order 
to achieve successful resolution of infection and it is likely that chemokines play a key role 
in this. Activated T cells can enter the CNS in an antigen-independent manner and rates of 
entry do increase when inflammatory responses are triggered in the periphery. However 
retention and anti-viral function are dependent on MHC restricted antigen recognition. Cells 
can enter the CNS through a number of routes (Ransohoff et al., 2003). The first is to cross 
the choroid plexus stromal venules, the region of the brain where CSF is produced, and can 
lead to an influx of cells within the CSF. Secondly, lymphocytes can enter through the 
vasculature supplying the pia membrane. Finally, lymphocytes can migrate into the 
parenchyma across vascular endothelium throughout the brain. This leads to the common 
histological feature observed during encephalitis of the perivascular cuff (Figure 3). 
Lymphocyte entry through the vasculature is divided into a series of events controlled by 
the expression of a range of adhesion molecules expressed on the lymphocyte and 
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endothelium (Ransohoff et al., 2003). The first stage is rolling or tethering as the cell becomes 
attached to the blood vessel. Critical amongst these are the intercellular adhesion molecules 
(ICAMs) that are stimulated within vascular endothelium by a range of cytokines directly or 
through positive feedback once adhesion has occurred between the lymphocyte and the 
endothelium (Dietrich, 2002). Finally the lymphocyte undergoes diapedesis, where 
processes extend between the endothelial cells, driven in part by chemokine-induced 
chemotaxis. 
 
Fig. 3. Example of a perivascular cuff forming around a parenchymal blood vessel observed 
within the brain following infection with a lyssavirus. The fixed section of murine brain has 
been paraffin mounted and stained with haematoxylin and eosin. There is distinct 
accumulation of mononuclear cells around the vessel  Further details can be found in Hicks 
et al. (Hicks et al., 2009). 
The current understanding of effector cell infiltration of the CNS suggests that the earliest 
responders to viral infection are T cells, whereas B cell development takes longer and these 
enter the CNS later in the course of infection (Savarin and Bergmann, 2008). T cells control 
virally infected cells whereas antibody is critical in controlling virus spread. However, in 
some instances there may also be antibody-mediated control of infected host cells through 
antibody-dependent cellular cytotoxicity. This mechanism may be more prominent in 
humans than in mice. 
B cells originate in the bone marrow and after development in this site, migrate as immature 
cells to secondary lymphoid tissues to complete the maturation process. B cells that 
encounter protein antigens through their B cell receptor can interact with primed T cells in a 
cognate-dependent manner (MacLennan et al., 2003). Productive contacts with T cells result 
in the B cell differentiating into antibody-secreting plasma cells in extrafollicular sites such 
as the splenic red pulp or medulla, in lymph nodes or entering the germinal centre reaction 
(MacLennan et al., 2003; Cozine et al., 2005). There are differences between these two 
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pathways. Extrafollicular responses develop to T-dependent and T-independent antigens 
and produce the first wave of IgM and IgG, the latter of which is generally of modest 
affinity. High affinity persisting, effective life-long antibody responses and memory B cells 
derive from germinal centres. In germinal centres B cells undergo somatic hypermutation 
with subsequent competition for antigen, and require further survival signals from T cells. 
Plasma cells that derive from this response then usually migrate to sites such as the bone 
marrow and secrete antibody. Thus, these effector cells can contribute to protection from 
sites distal from the sites of infection. Nevertheless, cells generated through the response 
may also be able to migrate to sites of inflammation, possibly through mechanisms such as 
their expression of CXCR3 resulting in migration to sites with elevated levels of CXCL10. 
What is significant in the context of the current discussion is that the type of B cell response 
induced and the kinetics in which it develops can vary markedly between different 
pathogens. Fundamental work on the development of antibodies has focused on the 
response to bacterial infection. For instance, in responses to alum-precipitated proteins 
extrafollicular and germinal centre responses develop in parallel, with both detectable 
within the first 5 days of immunization in mice. In contrast, extrafollicular responses to 
Salmonella infection are detectable within 3 days of systemic infection yet germinal centre 
responses do not develop until the infection has all but resolved (Cunningham et al., 2007). 
Furthermore, after infection with mycobacteria antibody responses may not be detectable 
until weeks after infection. This means that there are likely to be host-dependent and 
pathogen-dependent factors that shape the type and timing of the antibody response that is 
induced during infection. For rabies infection of humans this is likely to be important and 
possibly more influenced by pathogen-intrinsic factors, since post-exposure antibody is 
clearly able to control the infection if present early enough. 
The majority of cells undergoing migration across the CNS vasculature appear to be CD3+ T 
cells (Man et al., 2007). This is illustrated in Figure 4 where the average counts of T or B cells 
have been compared across three regions of the brain of a mouse infected with rabies virus. 
In each region over 90% of cells counted are T cells. Under normal conditions, low numbers 
of B cells can be detected in the CNS with an activated phenotype (Anthony et al., 2003). 
These presumably provide a low level of immune surveillance. The development of 
inflammation within the CNS causes this proportion to increase. The explanation for this 
may be in the longer development and maturation of B cells compared to other cell types 
prior to migration to the CNS. 
The evolution of intrathecal production of antibody has been demonstrated through 
introduction of antigen through a permanent cannula (Knopf et al., 1998). This study 
demonstrated trafficking of B cells into the CNS and detection of antigen-specific intrathecal 
antibody 14 days after injection. It was also observed that there was localisation of 
mononuclear cells at the site of antigen introduction suggesting a homing process. Similar 
kinetics have been demonstrated for antibody secreting cell entry into the CNS following 
viral infection with mouse hepatitis virus (Tschen et al., 2002). Four pathways have been 
proposed to account for the presence of antibody secreting cells within the CNS (Meinl et al., 
2006). These include migration of plasmablasts to the CNS, migration of memory B cells that 
subsequently differentiate into antibody-secreting cells, development of antibody secreting 
cells within lymphoid follicles in the meninges and antigen independent differentiation of B 
cells within the CNS itself. Recruitment and survival within the CNS is controlled by 
chemokines particularly CXCL12 / CXCL13 (Krumholz et al., 2006), and B cell promoting 
factors such as BAFF produced locally by astrocytes (Avery et al., 2003; Schneider, 2005). 
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The presence of antigen secreting cells can have both positive and negative effects within the 
CNS (Meinl et al., 2006). B cell secretion of cytokines such as TGF- can down-regulate 
inflammation whereas expression of IL-6 and IL-12 can increase tissue destruction. 
Similarly, secretion of antibodies that bind to autoantigens can lead to tissue damage as 
observed in multiple sclerosis lesions where B cells are prominent. However, secretion of 
antibodies against viruses will have a direct beneficial impact by controlling virus spread. 
One critical observation of B cells within the CNS is that they have undergone hypersomatic 
mutation, confirming that they have at some stage been present within a lymphoid germinal 
centre (Baranzini et al., 1999). This in turn suggests that the development of mature antibody 
secreting B cells requires a distinct period of time before it eventually reaches the CNS and 
that if excessive cell death has occurred during this period permanent damage may result. 
 
 
 
Fig. 4. Illustration of the proportion of T and B cells present with different regions of the 
brain following infection with rabies virus. Sections of murine brain were prepared and 
stained with anti-CD3 for T cells and anti-CD45R/B220 for B cells. 
6. Conclusions 
This review has attempted to follow the course of events that lead to the development of 
viral encephalitis from the viruses that cause it, through the early and late events of the host 
response. The proposed mechanisms that viruses use to cross the blood-brain barrier are 
limited and evidence for each is incomplete. The first, and one used by the most devastating 
viruses, is through direct infection of neurons within the periphery and effectively 
bypassing the BBB to infect neurons within the CNS. Examples include rabies virus and 
herpes viruses.  Pulzova and co-workers suggested three further methods by which 
pathogens can cross the endothelial barrier (Pulzova et al., 2009). The first involves direct 
infection of endothelial cells although this appears to be rare for viruses that invade the 
CNS. Secondly crossing between cells, again this is likely to be rare in the absence of other 
factors that might lead to a breakdown of the BBB although it has been proposed for West 
Nile virus (Verma et al., 2009). Finally, entry may result following transit within an infected 
cell, the so-called Trojan horse mechanism suggested for infection with HIV. Once within 
the CNS, viruses can spread rapidly. The consequences of uncontrolled viral-induced 
damage and subsequent un-regulated inflammation within the CNS can have severe 
consequences to the host. The brain is enclosed within the skull and the tough dural 
membranes so that there can be no increase in brain-case volume. This could occur in 
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response to increases in extracellular fluids or cellular content during inflammation with 
consequences for arterial influx and the possibility of ischaemia (Ransohoff et al., 2003). 
Furthermore, destruction of non-replaceable neurons can leave the patient with permanent 
disability, commonly observed following infections with Japanese encephalitis virus and 
West Nile virus, or death as happens following infection with rabies virus. Indeed, T cell 
infiltration has been associated with paralysis in experimental models of rabies virus 
infection (Sugamata et al., 1992). 
Infection and cellular destruction triggers the innate immune response that attracts immune-
effector cells with the aim of controlling virus replication. Viruses, in turn, possess 
mechanisms to inhibit the innate immune response, or in the case of herpesviruses are able 
to remain latent within infected neurons. This delays the host reponse providing a window 
for early rounds of virus replication. A further delay occurs through limited antigen 
presentation within the CNS. Early responders tend to be T cells and often appear to 
dominate the response when viewed at a single time-point (see Figure 4), whereas B-cells 
tend to enter later during the course of infection (Savarin and Bergmann, 2008). CD8 cells in 
particular have been shown in experimental models to be critical for clearance of some viral 
infections (Borrow et al., 1992) and control of others such as Herpes simplex infection (Lang 
and Nikolich-Zuglich, 2005). By contrast, antibody production within the CNS is considered 
critical to the control of rabies virus (Hooper et al., 2009). 
The difficulty in identifying the aetiological agent of encephalitis presents a real challenge to 
treatment. Herpes simplex viruses are the most common viral cause of encephalitis and are 
readily treatable with nucleoside analogues such as acyclovir. However, resistance has been 
observed leading to the development of alternatives such as helicase inhibitors and TLR 
agonists (Grauer et al., 2008; Wilson et al., 2009). Nitric oxide inhibitors have been suggested 
as a possible therapy in HIV to inhibit BBB disruption during HIV encephalopathy 
(Giovannoni et al., 1998). Recently, the use of therapeutic coma has been promoted as a 
method for treating rabies virus infection, particularly following the survival of a teenager 
using this treatment (Willoughby et al., 2005). However, numerous attempts to replicate this 
have not met with success (Maier et al., 2010; Hunter et al., 2010). Effective prevention for 
rabies, as with many other virus infections is best achieved by prior vaccination. Future 
alternatives to treatment of viral encephalitis may focus on innate immune agonists that will 
assist in the early anti-viral response. 
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